DÄ internationalArchive45/2018The nomenclature, definition and distinction of types of shock

cme

The nomenclature, definition and distinction of types of shock

Dtsch Arztebl Int 2018; 115(45): 757-68; DOI: 10.3238/arztebl.2018.0757

Standl, T; Annecke, T; Cascorbi, I; Heller, A R; Sabashnikov, A; Teske, W

LNSLNS
1.
Adams HA, Baumann G, Gänsslen A, et al.: Die Definitionen der Schockformen. Intensivmed 2001; 38: 541–53 CrossRef CrossRef
2.
Adams HA, Baumann G, Cascorbi I, et al.: Interdisziplinäre Behandlungspfade: Hypovolämischer Schock. Eine Empfehlung der IAG Schock der DIVI. Monographie Deutscher Ärzteverlag, Köln, 2010.
3.
Gänsslen A, Adams HA, Baumann G, et al.: Hämostase im Schock. Teil 4: Spezielle pathophysiologische Aspekte. Anästh Intensivmed 2016; 57: 58–67.
4.
Mutschler M, Nienaber U, Brockamp T, et al.: Renaissance of base deficit for the initial assessment of trauma patients: a base deficit based classification for hypovolemic shock developed on data from 16,305 patients derived from the Trauma Register DGU. Crit Care 2013, 17: R42 CrossRef MEDLINE PubMed Central
5.
Deitch E, Condon M, Feketeova E, et al.: Trauma-hemorrhagic shock induces a CD36-dependent RBC endothelial-adhesive phenotype. Crit Care Med 2014; 42: e200–10 CrossRef MEDLINE
6.
Slaughter A, Nunns G, Alessandro A, et al.: The metabolopathy of tissue injury, hemorrhagic shock and resuscitation in a rat model. Shock 2018; 49: 580–90 CrossRef MEDLINE
7.
Karamercan M, Weiss S, Villarroel J, et al.: Can peripheral blood mononuclear cells be used as a proxy for mitochondrial dysfunction in vital organs during hemorrhagic shock and resuscitation? Shock 2013; 40: 476–84 CrossRef MEDLINE PubMed Central
8.
Song R, Bian H, Wang X, Huang X, Zhao K: Mitochondrial injury underlies hyporeactivity of arterial smooth muscle in severe shock. Am J Hypertension 2011; 24: 45–51 CrossRef MEDLINE
9.
Sherren PB, Hussey J, Martin R, Kundishora T, Parker M and Emerson B: Acute burn induced coagulopathy. Burns 2013; 39: 1157–61 CrossRef MEDLINE
10.
Mitra B, Wasiak J, Cameron PA, O’Reilly G, Dobson H and Cleland H: Early coagulopathy of major burns. Injury 2013; 44: 40–3 CrossRef MEDLINE
11.
Lawton LD, Roncal S, Leonard E, et al.: The utility of advanced trauma life support (ATLS) clinical shock grading in assessment of trauma. Emerg Med J 2014; 31: 384–9 CrossRef MEDLINE
12.
Khan S, Davenport R, Raza I, et al.: Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage. Intensive Care Med 2015; 41: 239–47 CrossRef MEDLINE
13.
S3-Leitlinie Polytrauma/Schwerverletzten-Behandlung, AWMF Register-Nr. 012/019, Stand 7/2016.
14.
Shakur H, Roberts I, Bautista R, Caballero J, et al.: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23–32 CrossRef
15.
Roberts I, Shakur H, Afolabi A, et al.: The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096–101 CrossRef
16.
Shakur H, Roberts I, Fawole B, et al.: Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post- partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 2017; 389: 2105–16 CrossRef
17.
Rossaint R, Bouillon B, Vladimir Cerny V, et al.: The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Critical Care 2016; 20: 100 CrossRef MEDLINE PubMed Central
18.
Aoki K, Yoshino A, Yoh K, et al.: A comparison of Ringer’s lactate and acetate solutions and resuscitative effects on splanchnic dysoxia in patients with extensive burns. Burns 2010; 36: 1080–5 CrossRef MEDLINE
19.
Singer M, Deutschmann CS, Seymour CW, et al.: The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315: 801–10 CrossRef MEDLINE MEDLINE
20.
Fleischmann C, Thomas-Rueddel DO, Hartmann M, et al.: Hospital incidence and mortality rates of sepsis. Dtsch Arztebl Int 2016; 113: 159–66 VOLLTEXT
21.
Shankar-Hari M, Phillips GS, Levy ML, et al.: Developing a new definition and assessing new clinical criteria for septic shock. JAMA 2016; 315: 775–87 CrossRef MEDLINE PubMed Central
22.
Gotts EJ, Matthay MA: Sepsis: pathophysiology and clinical management. BMJ 2016; 353: i1585 CrossRef MEDLINE
23.
Delano MJ, Ward PA: The immune system`s role in sepsis progression, resolution, and long term outcome. Immunological Reviews 2016; 274: 330–53 CrossRef MEDLINE PubMed Central
24.
Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med 2013; 369: 840–51 CrossRef MEDLINE
25.
Vincent JL, De Backer D: Circulatory Shock. N Engl J Med 2013; 369: 1726–34 CrossRef MEDLINE
26.
Antonucci A, Fiaccadori E, Donadello K, et al.: Myocardial depression in sepsis: From pathogenesis to clinical manifestations and treatment. J Crit Care 2014; 29: 500–11 CrossRef MEDLINE
27.
Werdan K, Oelke A, Hettwer S, et al.: Septic cardiomyopathy: hemodynamic quantification, occurence, and prognostic implications. Clin Res Cardiol 2013; 100: 661–68 CrossRef MEDLINE
28.
Cecconi M, De Backer D, Antonelli M, et al.: Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 2014; 40: 1795–1815 CrossRef MEDLINE PubMed Central
29.
Rhodes A, Evans LE, Alhazzani W, et al.: Surviving Sepsis Campain: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 2017; 43: 302–77 CrossRef MEDLINE
30.
Triggiani M, Montagni M, Parente R, Ridolo E: Anaphylaxis and cardiovascular diseases: a dangerous liaison. Curr Opin Allergy Clin Immunol 2014;14: 309–15 CrossRef MEDLINE
31.
Ring J, Beyer K, Biedermann T, et al.: Guideline for acute therapy und management of anaphylaxis. S2 guideline. Allergo J Int 2014; 23: 96–112 CrossRef MEDLINE PubMed Central
32.
Pastrana EA, Saavedra FM, Murray G, et al.: Acute adrenal insufficiency in cervical spinal cord injury. World Neurosurg 2012; 77: 561–3 CrossRef MEDLINE
33.
Matsumoto T, Okuda S, Haku T, et al.: Neurogenic shock immediately following posterior lumbar interbody fusion. Global Spine J 2015; 5: e13–e6 CrossRef MEDLINE PubMed Central
34.
Summers RL, Baker SD, Sterling SA, et al.: Characterization of the spectrum of hemodynamic profiles in trauma patients with neurogenic shock. J Critical Care 2013; 28: 531.e1–531.e5 CrossRef MEDLINE PubMed Central
35.
Wood GC, Boucher AB, Johnson JL, et al.: Effectiveness of pseudoephedrine as adjunctive therapy for neurogenic shock after acute spinal cord injury: a case series. Pharmacotherapy 2014; 34: 89–93 CrossRef MEDLINE
36.
Furer A, Wessler J, Burkhoff D: Hemodynamics of cardiogenic shock. Interv Cardiol Clin 2017; 6: 359–71 CrossRef
37.
Werdan K, Russ M, Buerke M et al.: Deutsch-österreichische S3-Leitlinie Infarktbedingter kardiogener Schock – Diagnose, Monitoring und Therapie. Kardiologe 2011; 5: 166–224 CrossRef
38.
Nuding S, Werdan K, Prondzinsky R: Optimal course of treatment in acute cardiogenic shock complicating myocardial infarction. Expert Rev Cardiovasc Ther 2018; 16: 99–112 CrossRef MEDLINE
39.
Pich H, Heller AR: Obstruktiver Schock. Anaesthesist 2015; 64: 403–19 CrossRef MEDLINE
40.
Soar J, Nolan JP, Bottiger BW, et al.: European Resuscitation Council Guidelines for Resuscitation 2015: Section 3. Adult advanced life support. Resuscitation 2015; 95: 100–47 CrossRef CrossRef
Klinik für Anästhesie, Operative Intensiv- und Palliativmedizin, Städtisches Klinikum Solingen gGmbH: Prof. Dr. med. Thomas Standl, MHBA
Klinik für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Köln:
Prof. Dr. med. Thorsten Annecke, DESA
Institut für Experimentelle und Klinische Pharmakologie, Universitätsklinikum Schleswig-Holstein: Prof. Dr. med. Dr. rer. nat. Ingolf Cascorbi
Notaufnahme Zentrum Chirurgie, Klinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Carl Gustav Carus an der TU Dresden: Prof. Dr. med. Axel R. Heller, MBA, DEAA
Klinik und Poliklinik für Herz- und Thoraxchirurgie, Herzzentrum der Universitätsklinik Köln:
PD Dr. med. Anton Sabashnikov
Zentrum für Orthopädie und Unfallchirurgie, Kath. Krankenhaus Hagen gGmbH:
PD Dr. med. Wolfram Teske
1. Adams HA, Baumann G, Gänsslen A, et al.: Die Definitionen der Schockformen. Intensivmed 2001; 38: 541–53 CrossRef CrossRef
2. Adams HA, Baumann G, Cascorbi I, et al.: Interdisziplinäre Behandlungspfade: Hypovolämischer Schock. Eine Empfehlung der IAG Schock der DIVI. Monographie Deutscher Ärzteverlag, Köln, 2010.
3. Gänsslen A, Adams HA, Baumann G, et al.: Hämostase im Schock. Teil 4: Spezielle pathophysiologische Aspekte. Anästh Intensivmed 2016; 57: 58–67.
4. Mutschler M, Nienaber U, Brockamp T, et al.: Renaissance of base deficit for the initial assessment of trauma patients: a base deficit based classification for hypovolemic shock developed on data from 16,305 patients derived from the Trauma Register DGU. Crit Care 2013, 17: R42 CrossRef MEDLINE PubMed Central
5. Deitch E, Condon M, Feketeova E, et al.: Trauma-hemorrhagic shock induces a CD36-dependent RBC endothelial-adhesive phenotype. Crit Care Med 2014; 42: e200–10 CrossRef MEDLINE
6. Slaughter A, Nunns G, Alessandro A, et al.: The metabolopathy of tissue injury, hemorrhagic shock and resuscitation in a rat model. Shock 2018; 49: 580–90 CrossRef MEDLINE
7. Karamercan M, Weiss S, Villarroel J, et al.: Can peripheral blood mononuclear cells be used as a proxy for mitochondrial dysfunction in vital organs during hemorrhagic shock and resuscitation? Shock 2013; 40: 476–84 CrossRef MEDLINE PubMed Central
8. Song R, Bian H, Wang X, Huang X, Zhao K: Mitochondrial injury underlies hyporeactivity of arterial smooth muscle in severe shock. Am J Hypertension 2011; 24: 45–51 CrossRef MEDLINE
9. Sherren PB, Hussey J, Martin R, Kundishora T, Parker M and Emerson B: Acute burn induced coagulopathy. Burns 2013; 39: 1157–61 CrossRef MEDLINE
10.Mitra B, Wasiak J, Cameron PA, O’Reilly G, Dobson H and Cleland H: Early coagulopathy of major burns. Injury 2013; 44: 40–3 CrossRef MEDLINE
11. Lawton LD, Roncal S, Leonard E, et al.: The utility of advanced trauma life support (ATLS) clinical shock grading in assessment of trauma. Emerg Med J 2014; 31: 384–9 CrossRef MEDLINE
12. Khan S, Davenport R, Raza I, et al.: Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage. Intensive Care Med 2015; 41: 239–47 CrossRef MEDLINE
13. S3-Leitlinie Polytrauma/Schwerverletzten-Behandlung, AWMF Register-Nr. 012/019, Stand 7/2016.
14. Shakur H, Roberts I, Bautista R, Caballero J, et al.: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23–32 CrossRef
15. Roberts I, Shakur H, Afolabi A, et al.: The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096–101 CrossRef
16.Shakur H, Roberts I, Fawole B, et al.: Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post- partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 2017; 389: 2105–16 CrossRef
17. Rossaint R, Bouillon B, Vladimir Cerny V, et al.: The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Critical Care 2016; 20: 100 CrossRef MEDLINE PubMed Central
18. Aoki K, Yoshino A, Yoh K, et al.: A comparison of Ringer’s lactate and acetate solutions and resuscitative effects on splanchnic dysoxia in patients with extensive burns. Burns 2010; 36: 1080–5 CrossRef MEDLINE
19. Singer M, Deutschmann CS, Seymour CW, et al.: The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315: 801–10 CrossRef MEDLINE MEDLINE
20. Fleischmann C, Thomas-Rueddel DO, Hartmann M, et al.: Hospital incidence and mortality rates of sepsis. Dtsch Arztebl Int 2016; 113: 159–66 VOLLTEXT
21. Shankar-Hari M, Phillips GS, Levy ML, et al.: Developing a new definition and assessing new clinical criteria for septic shock. JAMA 2016; 315: 775–87 CrossRef MEDLINE PubMed Central
22. Gotts EJ, Matthay MA: Sepsis: pathophysiology and clinical management. BMJ 2016; 353: i1585 CrossRef MEDLINE
23. Delano MJ, Ward PA: The immune system`s role in sepsis progression, resolution, and long term outcome. Immunological Reviews 2016; 274: 330–53 CrossRef MEDLINE PubMed Central
24. Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med 2013; 369: 840–51 CrossRef MEDLINE
25. Vincent JL, De Backer D: Circulatory Shock. N Engl J Med 2013; 369: 1726–34 CrossRef MEDLINE
26. Antonucci A, Fiaccadori E, Donadello K, et al.: Myocardial depression in sepsis: From pathogenesis to clinical manifestations and treatment. J Crit Care 2014; 29: 500–11 CrossRef MEDLINE
27. Werdan K, Oelke A, Hettwer S, et al.: Septic cardiomyopathy: hemodynamic quantification, occurence, and prognostic implications. Clin Res Cardiol 2013; 100: 661–68 CrossRef MEDLINE
28. Cecconi M, De Backer D, Antonelli M, et al.: Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 2014; 40: 1795–1815 CrossRef MEDLINE PubMed Central
29. Rhodes A, Evans LE, Alhazzani W, et al.: Surviving Sepsis Campain: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 2017; 43: 302–77 CrossRef MEDLINE
30. Triggiani M, Montagni M, Parente R, Ridolo E: Anaphylaxis and cardiovascular diseases: a dangerous liaison. Curr Opin Allergy Clin Immunol 2014;14: 309–15 CrossRef MEDLINE
31. Ring J, Beyer K, Biedermann T, et al.: Guideline for acute therapy und management of anaphylaxis. S2 guideline. Allergo J Int 2014; 23: 96–112 CrossRef MEDLINE PubMed Central
32. Pastrana EA, Saavedra FM, Murray G, et al.: Acute adrenal insufficiency in cervical spinal cord injury. World Neurosurg 2012; 77: 561–3 CrossRef MEDLINE
33. Matsumoto T, Okuda S, Haku T, et al.: Neurogenic shock immediately following posterior lumbar interbody fusion. Global Spine J 2015; 5: e13–e6 CrossRef MEDLINE PubMed Central
34. Summers RL, Baker SD, Sterling SA, et al.: Characterization of the spectrum of hemodynamic profiles in trauma patients with neurogenic shock. J Critical Care 2013; 28: 531.e1–531.e5 CrossRef MEDLINE PubMed Central
35. Wood GC, Boucher AB, Johnson JL, et al.: Effectiveness of pseudoephedrine as adjunctive therapy for neurogenic shock after acute spinal cord injury: a case series. Pharmacotherapy 2014; 34: 89–93 CrossRef MEDLINE
36. Furer A, Wessler J, Burkhoff D: Hemodynamics of cardiogenic shock. Interv Cardiol Clin 2017; 6: 359–71 CrossRef
37. Werdan K, Russ M, Buerke M et al.: Deutsch-österreichische S3-Leitlinie Infarktbedingter kardiogener Schock – Diagnose, Monitoring und Therapie. Kardiologe 2011; 5: 166–224 CrossRef
38. Nuding S, Werdan K, Prondzinsky R: Optimal course of treatment in acute cardiogenic shock complicating myocardial infarction. Expert Rev Cardiovasc Ther 2018; 16: 99–112 CrossRef MEDLINE
39. Pich H, Heller AR: Obstruktiver Schock. Anaesthesist 2015; 64: 403–19 CrossRef MEDLINE
40. Soar J, Nolan JP, Bottiger BW, et al.: European Resuscitation Council Guidelines for Resuscitation 2015: Section 3. Adult advanced life support. Resuscitation 2015; 95: 100–47 CrossRef CrossRef